BREAKING: a saliva #COVID19
test developed by @YaleSPH researchers has recieved emergency use authorization by the FDA. #SalivaDirect is fast, inexpensive, and non-invasive. It can be a game changer for accessible testing. news.yale.edu/2020/08/15/yal…
test developed by @YaleSPH researchers has recieved emergency use authorization by the FDA. #SalivaDirect is fast, inexpensive, and non-invasive. It can be a game changer for accessible testing. news.yale.edu/2020/08/15/yal…
With the FDA’s emergency use authorization, the #SalivaDirect testing method is immediately available to other diagnostic laboratories that want to start using the new test, which can be scaled up quickly for use across the nation — and, perhaps, beyond.
"This is a huge step forward to make testing more accessible,” said Chantal Vogels, a @Yale postdoctoral fellow. Congratulations @VogelsChantal, @awyllie13, @NathanGrubaugh & team. And shout out to @NBA for their participation in making this happen.
"Wide-spread testing is critical for our control efforts... If cheap alternatives like SalivaDirect can be implemented across the country, we may finally get a handle on this pandemic, even before a vaccine,” said @NathanGrubaugh
The researchers who developed the test are not seeking to commercialize the method. Rather, they want the simplified testing method to help those most in need.
news.yale.edu/2020/08/15/yal…
news.yale.edu/2020/08/15/yal…
